Version history

{
  "session_id": "sess_SDA-2026-04-15-gap-pubmed-20260411-075338-35f913fb_20260416-034701",
  "round_number": 4,
  "agent_persona": "persona-synthesizer",
  "agent_backend": "minimax/MiniMax-M2.7",
  "action": "synthesize",
  "content": "\n\n```json\n{\n  \"ranked_hypotheses\": [\n    {\n      \"rank\": 1,\n      \"title\": \"Microglial NF-κB Repression via Co-repressor Complex Recruitment\",\n      \"mechanism\": \"HDAC9 overexpression recruits Class I HDAC3 to microglial promoters to repress NF-κB-mediated pro-inflammatory cytokine transcription (IL-1β, TNF-α), reducing neuroinflammation-driven Aβ production and synaptic toxicity.\",\n      \"target_gene\": \"HDAC3/NFKB1\",\n      \"confidence_score\": 0.68,\n      \"novelty_score\": 0.45,\n      \"feasibility_score\": 0.75,\n      \"impact_score\": 0.82,\n      \"composite_score\": 0.68,\n      \"testable_prediction\": \"RNA-seq of microglial transcriptomes from HDAC9-overexpressing vs. control mice crossed with 5xFAD mice, quantifying NF-κB target gene suppression and correlating with amyloid load reduction.\",\n      \"skeptic_concern\": \"Mechanistic directionality requires validation—does HDAC9 act upstream of NF-κB or as a downstream modulator of inflammatory tone?\"\n    },\n    {\n      \"rank\": 2,\n      \"title\": \"Synaptic Gene Regulation via Transcriptional Co-repression\",\n      \"mechanism\": \"HDAC9 acts as a scaffold to recruit Class I HDACs to activity-dependent synaptic gene promoters (e.g., Bdnf, Arc, c-fos), suppressing premature senescence-associated gene expression to maintain synaptic plasticity and cognitive function.\",\n      \"target_gene\": \"BDNF/ARC\",\n      \"confidence_score\": 0.62,\n      \"novelty_score\": 0.50,\n      \"feasibility_score\": 0.70,\n      \"impact_score\": 0.68,\n      \"composite_score\": 0.63,\n      \"testable_prediction\": \"ATAC-seq chromatin accessibility profiling in hippocampal neurons from HDAC9-overexpressing mice, identifying protected gene regulatory elements that correlate with rescued synaptic deficits.\",\n      \"skeptic_concern\": \"Delineating HDAC9's direct synaptic effects from indirect effects secondary to amyloid reduction requires circuit-level和行为 experiments.\"\n    },\n    {\n      \"rank\": 3,\n      \"title\": \"TFEB-Mediated Autophagy-Lysosomal Upregulation\",\n      \"mechanism\": \"HDAC9 promotes nuclear translocation of TFEB via indirect mechanisms (possibly through protein-protein interactions or altered HDAC3 recruitment dynamics), upregulating autophagy-lysosomal genes (CTSD, LAMP1, ATP6V1A) to clear Aβ deposits.\",\n      \"target_gene\": \"TFEB\",\n      \"confidence_score\": 0.38,\n      \"novelty_score\": 0.65,\n      \"feasibility_score\": 0.55,\n      \"impact_score\": 0.72,\n      \"composite_score\": 0.55,\n      \"testable_prediction\": \"Immunofluorescence quantification of TFEB nuclear/cytoplasmic ratio and qPCR of TFEB target genes in HDAC9-overexpressing neurons, with rescue experiments using TFEB siRNA to confirm dependency.\",\n      \"skeptic_concern\": \"Class IIa HDACs possess histidine-substituted active sites conferring minimal deacetylase activity; they function primarily as scaffolds recruiting Class I HDACs rather than direct deacetylases, requiring mechanistic revision.\"\n    }\n  ],\n  \"consensus_points\": [\n    \"Class IIa HDACs (HDAC4, 5, 7, 9) exhibit weak intrinsic deacetylase activity due to a histidine substitution in the catalytic pocket and function primarily as scaffolds recruiting Class I HDACs\",\n    \"HDAC9's therapeutic benefit in AD models is supported by reproducible phenotypic rescue of amyloid deposition and synaptic deficits\",\n    \"The microglial NF-κB repression pathway represents the most translationally tractable hypothesis given its alignment with AD clinical development strategies\"\n  ],\n  \"dissent_points\": [\n    \"Disagreement exists over whether HDAC9's primary protective mechanism operates through cell-autonomous neuronal effects (synaptic/cognitive protection) versus non-autonomous effects via microglial inflammatory modulation\"\n  ],\n  \"debate_summary\": \"The debate centered on reconciling HDAC9's Class IIa deacetylase-deficient mechanism with its protective effects in AD, revealing that while TFEB-autophagy remains conceptually attractive, it requires mechanistic revision given Class IIa catalytic limitations; consensus emerged that microglial NF-κB repression offers the most promising therapeutic angle, though circuit-level experiments are needed to disentangle direct synaptic effects from indirect amyloid-mediated rescue.\"\n}\n```",
  "tokens_used": "1055"
}